Trials / Completed
CompletedNCT04823455
Results Following Fresh-frozen Humeral Head Osteochondral Allograft Reconstruction for Reverse Hill-Sachs Lesion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Locked posterior glenohumeral dislocations with a reverse Hill-Sachs impaction fracture involving less than 30% of the humeral head are most frequently treated with lesser tuberosity transfer into the defect, whereas those involving more than 50% undergo humeral head arthroplasty. Reconstruction of the defect with segmental femoral osteochondral allografts has been proposed to treat patients between these two ranges, but the medium-/long-term outcomes of this joint-preserving procedure are controversial.
Detailed description
Twelve patients with a unilateral locked posterior shoulder dislocation and at least 30% (mean 31%) impaction of the humeral head were treated with segmental reconstruction of the defect with fresh-frozen humeral head osteochondral allografts. Patients were assessed clinically, radiographically and with computed tomography (CT) at a medium follow-up of 66 months (range, 24-225).All twelve shoulders presented a slight limitation in anterior elevation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | fresh-frozen humeral head osteochondral allograft reconstruction for reverse Hill-Sachs lesion | Between 2001 and 2018, a total of 12 consecutive patients were surgically treated for a locked posterior glenohumeral dislocation with a humeral head defect affecting at least 30% of the head diameter. During surgery, the bone defect was substituted with a fresh-frozen humeral head osteochondral allograft. |
Timeline
- Start date
- 2020-06-05
- Primary completion
- 2020-08-05
- Completion
- 2021-04-30
- First posted
- 2021-03-30
- Last updated
- 2024-09-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04823455. Inclusion in this directory is not an endorsement.